LAURUS LABS
Back to Balance Sheet
|
LAURUS LABS Last 5 Year Total Non-Current Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Non-Current Liabilities | ₹1,193 Cr | ₹1,159 Cr | ₹1,179 Cr | ₹928 Cr | ₹693 Cr |
What is the latest Total Non-Current Liabilities ratio of LAURUS LABS ?
| Year | Total Non-Current Liabilities |
|---|---|
| Mar2025 | ₹1,193 Cr |
| Mar2024 | ₹1,159 Cr |
| Mar2023 | ₹1,179 Cr |
| Mar2022 | ₹928 Cr |
| Mar2021 | ₹693 Cr |
How is Total Non-Current Liabilities of LAURUS LABS Trending?
| Years | Total Non-Current Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹1,193 Cr | 2.95 | |
| Mar2024 | ₹1,159 Cr | -1.72 | |
| Mar2023 | ₹1,179 Cr | 27.10 | |
| Mar2022 | ₹928 Cr | 33.94 | |
| Mar2021 | ₹693 Cr | - | |
Compare Total Non-Current Liabilities of peers of LAURUS LABS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| LAURUS LABS | ₹59,275.6 Cr | 3.7% | 7.5% | 74.7% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹397,018.0 Cr | -2.3% | -8.5% | -3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹162,454.0 Cr | 5.3% | -3.4% | 3.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹140,702.0 Cr | 3.7% | -4.9% | 26% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹102,830.0 Cr | 1.2% | -4.2% | 5.3% | Stock Analytics | |
| CIPLA | ₹99,325.0 Cr | 2.4% | -7.2% | -18.1% | Stock Analytics | |
LAURUS LABS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| LAURUS LABS | 3.7% |
7.5% |
74.7% |
| SENSEX | 5.8% |
-1.7% |
1.2% |
You may also like the below Video Courses